QT Imaging Holdings Earnings Call Transcripts
Fiscal Year 2026
-
Q1 2026 saw 133% revenue growth year-over-year, driven by increased scanner shipments and software innovation. Regulatory and reimbursement milestones, including FDA and AMA approvals, support strong 2026 guidance and international expansion.
Fiscal Year 2025
-
Record 2025 revenue and scanner shipments drove strong growth, with international expansion and new regulatory clearances positioning the company for continued momentum. 2026 guidance projects revenue to more than double, supported by multi-year distribution contracts and cloud platform monetization.
-
Q3 2025 saw strong revenue growth and improved operating loss, driven by increased scanner shipments and a robust commercial strategy. The company reaffirmed 2025 and 2026 sales guidance, strengthened its balance sheet, and advanced regulatory and reimbursement milestones.